Recent Onset

Sub-Areas to Recent Onset:

Site-Specific Intervention (3)
Systemic Intervention (0)
Combination Therapy (1)


(Journal Article): Mucosal Tolerance to Prevent Type 1 Diabetes: Can the Outcome Be Improved in Humans?
 
Hanninen A, Harrison LC
 
IN: Rev Diabetic Stud 2004; 1(3):113-121
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: The results of trials in which autoantigens have been fed to individuals affected by autoimmune diseases - multiple sclerosis, rheumatoid arthritis and type 1 diabetes - have been ... Click HERE for details

 

(Journal Article): CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
 
Thornton AM, Shevach EM
 
IN: J Exp Med 1998; 188(2):287-296
Impact Factor(s) of J Exp Med: 14.588 (2004), 15.302 (2003), 15.34 (2001)

ABSTRACT: Peripheral tolerance may be maintained by a population of regulatory/suppressor T cells that prevent the activation of autoreactive T cells recognizing tissue-specific antigens. We... Click HERE for details

 



 
Contribute to this subject area!